These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 410919)
1. Identification of urinary catechol and methylated catechol metabolites of phenytoin in humans, monkeys, and dogs by GLC and GLC-mass spectrometry. Midha KK; Hindmarsh KW; McGilveray IJ; Cooper JK J Pharm Sci; 1977 Nov; 66(11):1596-602. PubMed ID: 410919 [TBL] [Abstract][Full Text] [Related]
2. Identification of 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin as a metabolite of 5,5-diphenylhydantoin (phenytoin) in rats and man. Borgå O; Garle M; Gutová M Pharmacology; 1972; 7(3):129-37. PubMed ID: 5054584 [No Abstract] [Full Text] [Related]
3. Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism. Maguire JH Epilepsia; 1988; 29(6):753-9. PubMed ID: 3191891 [TBL] [Abstract][Full Text] [Related]
4. Stereochemical aspects of the metabolism of 5-(4'-fluorophenyl)-5-phenylhydantoin in the rat. Poupaert JH; Adline J; Claesen MH; De Laey P; Dumont PA J Med Chem; 1979 Sep; 22(9):1140-2. PubMed ID: 490562 [TBL] [Abstract][Full Text] [Related]
5. Identification and synthesis of a methylated catechol metabolite of glutethimide isolated from biological fluids of overdose victims. Andresen BD; Davis FT; Long MD J Pharm Sci; 1979 Mar; 68(3):283-8. PubMed ID: 423115 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin. Billings RE J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524 [TBL] [Abstract][Full Text] [Related]
7. Sensitive GLC procedure simultaneous determination of phenytoin and its major metabolite from plasma following single doses of phenytoin. Midha KK; McGilveray IJ; Wilson DL J Pharm Sci; 1976 Aug; 65(8):1240-3. PubMed ID: 978445 [TBL] [Abstract][Full Text] [Related]
8. A 3-O-methylated catechol metabolite of diphenylhydantoin (Dilantin) in rat urine. Chang T; Okerholm RA; Glazko AJ Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):13-23. PubMed ID: 4671868 [No Abstract] [Full Text] [Related]
9. Comparative biotransformation of triflubazam in rats, dogs, and monkeys. Alton KB; Patrick JE; Shaw C; McGuire JL Drug Metab Dispos; 1975; 3(6):445-52. PubMed ID: 1219 [TBL] [Abstract][Full Text] [Related]
10. Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin. Atkinson AJ; MacGee J; Strong J; Garteiz D; Gaffney TE Biochem Pharmacol; 1970 Aug; 19(8):2483-91. PubMed ID: 5520606 [No Abstract] [Full Text] [Related]
11. Phenytoin metabolism in infants following intravenous and oral administration. Leff RD; Fischer LJ; Roberts RJ Dev Pharmacol Ther; 1986; 9(4):217-23. PubMed ID: 3757729 [TBL] [Abstract][Full Text] [Related]
12. Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dog. Wikberg T; Ottoila P; Taskinen J Eur J Drug Metab Pharmacokinet; 1993; 18(4):359-67. PubMed ID: 8020535 [TBL] [Abstract][Full Text] [Related]
13. Identification of a catechol glucuronide metabolite of 5,5-diphenylhydantoin (DPH) in rat bile by gas chromatography (GC) and mass spectrometry (MS). Gerber N; Seibert RA; Thompson RM Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):499-511. PubMed ID: 4750099 [No Abstract] [Full Text] [Related]
14. Oxygen-18 incorporation studies of the metabolism of phenytoin to the catechol. Billings RE; Fischer LJ Drug Metab Dispos; 1985; 13(3):312-7. PubMed ID: 2861989 [TBL] [Abstract][Full Text] [Related]
15. In vivo phenolic metabolites of N-alkylamphetamines in the rat. Evidence in favor of catechol formation. Coutts RT; Dawson GW; Kazakoff CW; Wong JY Drug Metab Dispos; 1976; 4(3):256-61. PubMed ID: 6230 [TBL] [Abstract][Full Text] [Related]
16. Search for 5-(2-hydroxyphenyl)-5-phenylhydantoin as a metabolite of phenytoin. Poupaert JH; Moustafa M; Smeyers C; Adline J; Vandervorst D; Claesen M; Dumont P J Pharm Belg; 1982; 37(1):47-52. PubMed ID: 7077512 [No Abstract] [Full Text] [Related]
17. Use of stable isotopes in the study of pharmacokinetics of drugs by mass fragmentography II: Detailed examination of pharmacokinetics of a single oral dose of phenytoin in humans. Baba S; Goromaru T; Yamazaki K; Kasuya Y J Pharm Sci; 1980 Nov; 69(11):1300-7. PubMed ID: 7452459 [TBL] [Abstract][Full Text] [Related]
18. Further studies on the metabolism of carbidopa, (minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate, in the human, Rhesus monkey, dog, and rat. Vickers S; Stuart EK; Hucker HB J Med Chem; 1975 Feb; 18(2):134-8. PubMed ID: 804550 [TBL] [Abstract][Full Text] [Related]
19. Isolation and identification of morphine n-oxide alpha- and beta-dihydromorphines, beta- or gamma-isomorphine, and hydroxylated morphine as morphine metabolites in several mammalian species. Yeh SY; Krebs HA; Gorodetzky CW J Pharm Sci; 1979 Feb; 68(2):133-40. PubMed ID: 106104 [TBL] [Abstract][Full Text] [Related]
20. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog. Moustafa MA; Claesen M; Adline J; Vandervorst D; Poupaert JH Drug Metab Dispos; 1983; 11(6):574-80. PubMed ID: 6140142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]